temple-ventures

Details

button.114911.111432.131252When: April 24, 2015
Where: Temple University – Serc Building
1925 N. 12th Street, Philadelphia, PA
Time: 10:00 AM – 12:00 PM

Agenda

10:00-11:00
Refreshments, Networking, and Technology Showcase

  • Next Generation Antimicrobial Agents
    Dr. William Wuest Assistant Professor of Chemistry, College of Science and Technology;
  • New Therapeutic Approach for ALS (LouGehrig’s Disease)
    Dr. Benjamin Blass, Assistant Professor of Medicinal Chemistry,
    Moulder Center for Drug Discovery Research, School of Pharmacy;
  • Tactile Imaging System for Detecting Malignant TUMORS
    Dr. Change-Hee Won, P.h.D., Associate Professor – Electrical & Computer Engineering,
    College of Engineering;
  • Automatic Generation of EEG Reports Using Deep Learning
    Dr. Joseph Picone, Professor of Electrical & Computer Engineering, and Dr. Iyad Obeid, Associate Professor, Electrical & Computer Engineering, College of Engineering;
  • Novel Diagnostic Approach to Identify JC Virus Reactivation and Predict PML Development
    Dr. Kamel Khalili, Laura H. Carnell Professor and Chair and Dr. Ilker Saryier, Assistant Professor, Department of Neuroscience, School of Medicine;
  • Phage Technology for Antibiotic-Resistant Infections
    Dr. Roy Stevens, Henry Isaiah Dorr Professor of Dental Research; Director, Oral Infectious
    Diseases Research Laboratory; Associate Dean for Research, School of Dentistry;
  • Novel, Low-cost, Regenerable Water Filter Technology
    Dr. Rominder Suri, Chair & Professor, Civil & Environmental Engineering; Director,
    Water and Environmental Technology Center

11:10-11:10
Welcome by Michele Masucci, P.h.D., Vice Provost for Research

11:10-11:20
Neil D. Theobald, P.h.D., President of Temple University

11:20-11:30
RoseAnn B. Rosenthal, Ph.D., President & CEO, Ben Franklin Technology Partners of Southeastern Pennsylvania

11:30-11:40
Congressman Chaka Fattah, U.S. Representative for
Pennsylvania’s 2nd Congressional District

11:40-11:45
Ramesh Kumar, Ph.D., President and CEO, Onconova Therapeutics

11:45-12:00
Michele Masucci, Ph.D., Closing remarks

 

 

Click Here to RSVP
For more information about Temple Ventures, please click here.